MitraGen is a medical device company formed to complete the development and commercialize Transcatheter Mitral Valve Repair--Annuloplsty technologies. These technologies will allow the interventional cardiologist to repair the mitral valve for treatment of functional mitral regurgitation (FMR) and congestive heart failure (CHF) in a minimally invasive cardiac cath lab procedure avoiding the need for open heart surgery.